1. Home
  2. AAOI vs IBRX Comparison

AAOI vs IBRX Comparison

Compare AAOI & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Optoelectronics Inc.

AAOI

Applied Optoelectronics Inc.

HOLD

Current Price

$38.11

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$2.19

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAOI
IBRX
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AAOI
IBRX
Price
$38.11
$2.19
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$33.60
$9.71
AVG Volume (30 Days)
5.5M
13.5M
Earning Date
02-25-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$421,712,000.00
$82,555,000.00
Revenue This Year
$85.86
$667.18
Revenue Next Year
$64.48
$93.03
P/E Ratio
N/A
N/A
Revenue Growth
101.25
1025.95
52 Week Low
$9.71
$1.83
52 Week High
$41.96
$4.27

Technical Indicators

Market Signals
Indicator
AAOI
IBRX
Relative Strength Index (RSI) 58.77 52.47
Support Level $34.02 $1.95
Resistance Level $41.35 $2.29
Average True Range (ATR) 3.62 0.10
MACD 0.09 0.01
Stochastic Oscillator 76.25 69.12

Price Performance

Historical Comparison
AAOI
IBRX

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: